Back to Search
HARVEY HURWITZ, M.D.
M.D.
Internal Medicine Physician
NPI: 1659572683Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
100990-1(NY)
Research & Publications (20)
Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study.
PMID 18685900·J Gastrointest Surg·2009
4-observational
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials.
PMID 19064978·J Clin Oncol·2009
2-rct
Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
PMID 18805651·Int J Radiat Oncol Biol Phys·2009
8-other
Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression.
PMID 19652084·Hypertension·2009
7-preclinical
The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
PMID 19144677·Oncologist·2009
3-trial
Phase I trial of pazopanib in patients with advanced cancer.
PMID 19509175·Clin Cancer Res·2009
3-trial
Bevacizumab improves the overall and progression-free survival of patients with metastatic colorectal cancer treated with 5-fluorouracil-based regimens irrespective of baseline risk.
PMID 18852492·Oncology·2008
8-other
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.
PMID 18193223·Cancer Immunol Immunother·2008
8-other
Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?
PMID 19385771·J Empir Res Hum Res Ethics·2008
8-other
Physicians pay attention: you aren't testing your patients adequately for kidney disease!
PMID 18449365·Medscape J Med·2008
8-other
A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
PMID 17881149·Int J Radiat Oncol Biol Phys·2008
3-trial
Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
PMID 18182660·J Clin Oncol·2008
4-observational
Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
PMID 18155574·J Am Coll Surg·2008
4-observational
A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer.
PMID 18829508·Clin Cancer Res·2008
3-trial
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
PMID 18776057·Oncologist·2008
3-trial
Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
PMID 17689032·Int J Radiat Oncol Biol Phys·2007
4-observational
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.
PMID 17686822·J Natl Cancer Inst·2007
1-meta
Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer.
PMID 17889266·Int J Radiat Oncol Biol Phys·2007
4-observational
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
PMID 17947727·J Clin Oncol·2007
3-trial
Readers respond to "it is time to extend the laboratory critical (panic) value system to include vital values".
PMID 17955067·MedGenMed·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 BROAD ST
PLATTSBURGH, NY 12901 - Phone
- (518) 564-2187
Quick Facts
- NPI
- 1659572683
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile